Thesis (M.Sc.) - Cairo University - Faculty of Medicine - Department of Neuropsychiatry

The combination of a substance use disorder and other anxiety disorder is recognized to be increasingly common. It seems likely that substance misuse can activate new psychiatric disorders and aggravate current disorder (Johnson, 1997). Anxiety disorders are also highly comorbid with substance use disorders (Brady and Kendall 1992. Costello et al., 2003). Anxiety and substance use disorders can coexist (i.e., the two disorders may exist independently) (Kaplan and Sadock, 2003). Objectives: The aim of this study is: To assess the presence of anxiety disorders in patients with substance use disorder. To determine the common types of anxiety disorders among substance dependents. Subjects and methods: The study included 80 subjects, who were divided into two groups: Group 1: 50 subjects diagnosed with substance use disorder. Group 2: 30 healthy controls. The patients were all recruited from the outpatient clinic of the psychiatry and Addiction prevention Hospital in Al Kasr Al Ainy. Healthy controls were recruited from patients' relatives. Group 1 were subjected to the following: Full details clinical sheet. The Structured Clinical Interview for DSM-IV Axis I disorders (SCID-I) for anxiety disorders and Substance dependence disorder> Group 2 were subjected to the following: General health questionnaire. Both groups 1 and 2 were subjected to the following: An informed consent. Urine screening test. Results: The dual diagnosis between anxiety and co-occurring substance use disorders is a common but serious clinical problem. This comorbidity (48 % in recovered cases) tends to complicate treatment, management, and prognosis of both disorders. The specific phobic disorder has the most prevalent type in recovered patients (20%) followed by social anxiety disorder (18%), generalized anxiety disorder (16.3%), agoraphobia without panic disorder (12 %), Panic disorder (12%), post-traumatic stress disorder (8%), The obsessive compulsive disorder (6%) finally body dysmorphic disorder 2%

Issued also as CD